| Literature DB >> 33158986 |
Surya Banerjee1, Shimshon Benji1, Sarah Liberow1, Josefa Steinhauer2.
Abstract
Since the dawn of the 20th century, the fruit fly Drosophila melanogaster has been used as a model organism to understand the nature of genes and how they control development, behavior, and physiology. One of the most powerful experimental approaches employed in Drosophila is the forward genetic screen. In the 21st century, genome-wide screens have become popular tools for identifying evolutionarily conserved genes involved in complex human diseases. In the accompanying article "Amyotrophic Lateral Sclerosis Modifiers in Drosophila Reveal the Phospholipase D Pathway as a Potential Therapeutic Target," Kankel and colleagues describe a forward genetic modifier screen to discover factors that contribute to the severe neurodegenerative disease amyotrophic lateral sclerosis (ALS). This primer briefly traces the history of genetic screens in Drosophila and introduces students to ALS. We then provide a set of guided reading questions to help students work through the data presented in the research article. Finally, several ideas for literature-based research projects are offered as opportunities for students to expand their appreciation of the potential scope of genetic screens. The primer is intended to help students and instructors thoroughly examine a current study that uses forward genetics in Drosophila to identify human disease genes.Entities:
Keywords: ALS; Drosophila; education; genetic screen; neurodegeneration
Mesh:
Year: 2020 PMID: 33158986 PMCID: PMC7648582 DOI: 10.1534/genetics.120.303495
Source DB: PubMed Journal: Genetics ISSN: 0016-6731 Impact factor: 4.562